{
    "2021-02-22": [
        [
            {
                "time": "2021-02-15",
                "original_text": "UPDATE 2-Pfizer to ship 13 mln COVID-19 vaccine doses per week to U.S. by mid-March, says executive",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "vaccine",
                        "doses",
                        "U.S.",
                        "mid-March"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-02-22",
                "original_text": "Coronavirus update: US surpasses 500K deaths; FDA addresses variants and vaccines",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "US",
                        "deaths",
                        "FDA",
                        "variants",
                        "vaccines"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-23",
                "original_text": "U.S. COVID deaths top 500,000 as experts look to FDA meeting on J&J’s one-dose vaccine",
                "features": {
                    "keywords": [
                        "U.S.",
                        "COVID",
                        "deaths",
                        "FDA",
                        "J&J",
                        "vaccine"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-24",
                "original_text": "Why Novavax Stock Sank Today",
                "features": {
                    "keywords": [
                        "Novavax",
                        "Stock",
                        "Sank",
                        "Today"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-25",
                "original_text": "U.S. edges closer to half a million COVID deaths as experts look to FDA meeting on J&J’s one-dose vaccine",
                "features": {
                    "keywords": [
                        "U.S.",
                        "COVID",
                        "deaths",
                        "FDA",
                        "J&J",
                        "vaccine"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-26",
                "original_text": "Sanofi and GlaxoSmithKline Start Phase 2 Trial of Delayed Covid-19 Vaccine",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "GlaxoSmithKline",
                        "Phase",
                        "Trial",
                        "Covid-19",
                        "Vaccine"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-02-27",
                "original_text": "FDA committee to review J&J's COVID-19 vaccine candidate on Thursday",
                "features": {
                    "keywords": [
                        "FDA",
                        "committee",
                        "review",
                        "J&J",
                        "COVID-19",
                        "vaccine"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-02-28",
                "original_text": "Sanofi/GlaxoSmithKline Initiate COVID-19 Vaccine Development After Setback",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "GlaxoSmithKline",
                        "Initiate",
                        "COVID-19",
                        "Vaccine",
                        "Development",
                        "Setback"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "Sanofi, GSK Restart Trials on Covid-19 Vaccine After Delay",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "GSK",
                        "Restart",
                        "Trials",
                        "Covid-19",
                        "Vaccine",
                        "Delay"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}